scPharmaceuticals SCPH is set to give its latest quarterly earnings report on Wednesday, 2024-11-13. Here's what investors need to know before the announcement.
Analysts estimate that scPharmaceuticals will report an earnings per share (EPS) of $-0.30.
The announcement from scPharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Past Earnings Performance
During the last quarter, the company reported an EPS missed by $0.04, leading to a 5.64% increase in the share price on the subsequent day.
Here's a look at scPharmaceuticals's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.40 | -0.44 | -0.42 | -0.36 |
| EPS Actual | -0.44 | -0.36 | -0.35 | -0.41 |
| Price Change % | 6.0% | 2.0% | -3.0% | -9.0% |
Market Performance of scPharmaceuticals's Stock
Shares of scPharmaceuticals were trading at $4.23 as of November 08. Over the last 52-week period, shares are down 16.07%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.
To track all earnings releases for scPharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
